These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 14557375)
1. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK. Small GW; Somasundaram S; Moore DT; Shi YY; Orlowski RZ J Pharmacol Exp Ther; 2003 Dec; 307(3):861-9. PubMed ID: 14557375 [TBL] [Abstract][Full Text] [Related]
2. Evidence that mitogen-activated protein kinase phosphatase-1 induction by proteasome inhibitors plays an antiapoptotic role. Small GW; Shi YY; Edmund NA; Somasundaram S; Moore DT; Orlowski RZ Mol Pharmacol; 2004 Dec; 66(6):1478-90. PubMed ID: 15448190 [TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer. Shi YY; Small GW; Orlowski RZ Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678 [TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance. Small GW; Shi YY; Higgins LS; Orlowski RZ Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361 [TBL] [Abstract][Full Text] [Related]
5. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice. Marchetti S; Gimond C; Roux D; Gothié E; Pouysségur J; Pagès G J Cell Physiol; 2004 Jun; 199(3):441-50. PubMed ID: 15095291 [TBL] [Abstract][Full Text] [Related]
6. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells. Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death. Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649 [TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070 [TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin. Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1. Newton R; King EM; Gong W; Rider CF; Staples KJ; Holden NS; Bergmann MW Biochem J; 2010 Mar; 427(1):113-24. PubMed ID: 20100175 [TBL] [Abstract][Full Text] [Related]
11. Temporal regulation of light-induced extracellular signal-regulated kinase activation in the suprachiasmatic nucleus. Butcher GQ; Lee B; Obrietan K J Neurophysiol; 2003 Dec; 90(6):3854-63. PubMed ID: 12930817 [TBL] [Abstract][Full Text] [Related]
12. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids. Toh ML; Yang Y; Leech M; Santos L; Morand EF Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200 [TBL] [Abstract][Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
14. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. Brunet A; Roux D; Lenormand P; Dowd S; Keyse S; Pouysségur J EMBO J; 1999 Feb; 18(3):664-74. PubMed ID: 9927426 [TBL] [Abstract][Full Text] [Related]
15. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Zhou JY; Liu Y; Wu GS Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445 [TBL] [Abstract][Full Text] [Related]
16. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway. Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639 [TBL] [Abstract][Full Text] [Related]